What is Kymera Therapeutics's investment proceeds?

Kymera Therapeutics (KYMR) reported investment proceeds of $133.86M in Q1 2026.

How has Kymera Therapeutics's investment proceeds changed year-over-year?

Kymera Therapeutics's investment proceeds increased by 0.8% year-over-year, from $132.74M to $133.86M.

What does investment proceeds mean?

Cash received from sales, maturities, and redemptions of investment securities across all categories.

Kymera Therapeutics KYMR Investment Proceeds

Investment Proceeds at other companies

ImmunityBio, Inc.IBRX

$79.38M+1,384%

Krystal Biotech, Inc.KRYS

$103.6M+16.7%

Spyre Therapeutics, Inc.SYRE

$107.75M+50.9%

IncyteINCY

$0-100%

TG TherapeuticsTGTX

$11.25M-86.0%

Protagonist TherapeuticsPTGX

——

Other financials

Income statement

See full

Revenue$34.4M+55.5%

Operating income-$84.2M-13.1%

Net income-$69.2M-5.6%

EPS (diluted)-$0.71+13.4%

Balance sheet

See full

Cash & equivalents$144.1M+60.2%

Total debt$82.2M-6.5%

Total equity$1.5B+95.8%

Total assets$1.7B+81.7%

Cash flow

See full

Operating cash flow-$88.8M-12.2%

CapEx$434.0K-7.1%

Free cash flow-$89.3M-12.1%

Valuation

See full

Market cap$7.44B+283%

Enterprise value$7.38B+280%

P/S144.5×+111×

Profitability

See full

Operating margin-697.7%+635pp

Net margin-612%+602pp

FCF margin-474%+92.4pp

Returns & leverage

See full

Return on equity-27.1%-3.7pp

Debt / equity0.1×-0.1×

Current ratio10.8×+2.3×

Where this comes from

Reported directly by Kymera Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments.

The official record: Kymera Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kymera Therapeutics's investment proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Kymera Therapeutics's investment proceeds?: Kymera Therapeutics (KYMR) reported investment proceeds of $133.86M in Q1 2026.
How has Kymera Therapeutics's investment proceeds changed year-over-year?: Kymera Therapeutics's investment proceeds increased by 0.8% year-over-year, from $132.74M to $133.86M.
What does investment proceeds mean?: Cash received from sales, maturities, and redemptions of investment securities across all categories.